Enumera Molecular, Inc. — Form D/A
Enumera Molecular, Inc. of ANN ARBOR, MI, a company, filed a Form D amendment with the SEC on 2022-08-22. The offering totals $19.0M, of which $18.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-08-22
- Form: D/A
- Accession: 0001929085-22-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $19.0M
- Amount sold: $18.7M
- Remaining: $250K
- Investors: 5
- Date of first sale: 2022-05-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-445914
Issuer
- Name: Enumera Molecular, Inc.
- CIK: 0001929085
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 600 S. WAGNER RD. BLDG. 1, ANN ARBOR, MI, 48103
- Phone: 650-308-8544
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Matthew Cooper | Director | Ann Arbor, MI |
| Matthew Cooper | Executive Officer | Ann Arbor, MI |
| Matthew Cooper | Related Person | Ann Arbor, MI |
| Elaine Heron | Related Person | Ann Arbor, MI |
| Dan Kidle | Related Person | Ann Arbor, MI |
| Sundaresh Brahmasandra | Related Person | Ann Arbor, MI |
Other filings by this issuer (2)
More